The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Exacerbation of Idiopathic Interstitial Pneumonias Associated with Lung Cancer Therapy
Open accessAbstract
OBJECTIVE AND METHODS: Idiopathic interstitial pneumonias (IIPs) frequently occur in association with lung cancer. However, there is no consensus on the best treatment of acute exacerbation of IIP in lung cancer patients (LC with IIP), including those with iatrogenic acute lung injury resulting from cancer treatments. We aimed to identify an appropriate strategy for treatment of this condition. We analyzed clinical features of 120 LC with IIP, retrospectively. RESULTS: The incidence of acute exacerbation related to anticancer treatment was 22.7%; when the incidence was examined separately for patients receiving chemotherapy or the best supportive care, the incidence was 20.0% and 31.3%, respectively. Additional investigations should be directed to finding suitable regimens for treatment of LC with IIP and the selection of appropriate patients with LC with IIP for chemotherapy. The incidence of acute exacerbation caused by combination regimens of carboplatin + paclitaxel or a platinum agent + etoposide was significantly lower than that of other regimens (0% vs. 18%, respectively; p=0.025, Fisher's Exact Test). Patients with high levels of C-reactive protein before chemotherapy had a significantly higher risk of developing acute exacerbation (odds ratio 5.60, p=0.028). CONCLUSION: There was no evidence that anticancer treatment, including chemotherapy, should be avoided in LC with IIP. To establish an appropriate cancer treatment for LC with IIP, a prospective clinical study should be performed to evaluate various treatment modalities in a larger patient population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, drug‑induced lung injury occurs more frequently in groups with high CRP, SUVmax, or GPS(32‑34).”
From Clinical impact of inflammatory and nutrition index based on metabolic tumor activity in non‑small cell lung cancer treated with immunotherapy. (2024) · cites this paper as [32]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.2.ats01 · Cited by 4,196
Double-blind, Placebo-controlled Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
Azuma, A., Nukiwa, T., Tsuboi, E., Suga, M., Abe, S., Nakata, K., Taguchi, Y., Nagai, S., Itoh, H., Ohi, M., et al. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200404-571oc · Cited by 955
Self-citationLung Cancer and Cryptogenic Fibrosing Alveolitis: A Population-based Cohort Study
Hubbard, R., Venn, A. J., Lewis, S., & Britton, J. R. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.1.9906062 · Cited by 637
Interstitial Lung Disease in Japanese Patients with Lung Cancer
Kudoh, S., Kato, H., Nishiwaki, Y., Fukuoka, M., Nakata, K., Ichinose, Y., Tsuboi, M., Yokota, S., Nakagawa, K., Suga, M., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200710-1501oc · Cited by 477
Self-citationAcute Exacerbation in Idiopathic Pulmonary Fibrosis
Kondoh, Y., Taniguchi, H., Kawabata, Y., Yokoi, T., Suzuki, K., & Takagi, K. (1993) · CHEST Journal · doi:10.1378/chest.103.6.1808 · Cited by 457
Raghu, G., Mageto, Y. N., Lockhart, D., Schmidt, R. A., Wood, D. E., & Godwin, J. D. (1999) · CHEST Journal · doi:10.1378/chest.116.5.1168 · Cited by 401
Clinical deterioration in patients with idiopathic pulmonary fibrosis: Causes and assessment
Panos, R. J., Mortenson, R. L., Niccoli, S. A., & King, T. E. (1990) · The American Journal of Medicine · doi:10.1016/0002-9343(90)90495-y · Cited by 367
Cryptogenic fibrosing alveolitis and lung cancer.
Turner-Warwick, M. E. H., Lebowitz, M. D., Burrows, B. A., & Johnson, A. (1980) · Thorax · doi:10.1136/thx.35.7.496 · Cited by 348
Anscher, M. S., Peters, W. P., Reisenbichler, H., Petros, W. P., & Jirtle, R. L. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306033282203 · Cited by 316
Akira, M., Hamada, H., Sakatani, M., Kobayashi, C., Nishioka, M., & Yamamoto, S. (1997) · American Journal of Roentgenology · doi:10.2214/ajr.168.1.8976924 · Cited by 298
Research works printed but not linked: 6
- UEMATSU K, 2001, Cancer Res, 61, 8527
- KOIZUMI K, 2004, Ann Thorac Cardiovasc Surg, 10, 340
- American Thoracic Society, 2002, Am J Respir Crit Care Med, 165, 277, 10.1164/ajrccm.165.2.ats01 · DOI · Paper page
- Takeuchi E, Yamaguchi T, Mori M, et, 1996, Nihon Kyobu Shikkan Gakkai Zasshi, 34, 653
- Gemma A, Seike M, Kosaihira S, et a, 2006, Anticancer Res, 26, 3083
- Fukushima K, Kawabata Y, Uchiyama T, 1999, Nihon Kokyuuki Gakkai Zassi, 37, 177
Cited by
Sorted by citations
Satō, T., Teramukai, S., Kondo, H., Watanabe, A., Ebina, M., Kishi, K., Fujii, Y., Mitsudomi, T., Yoshimura, M., Maniwa, T., et al. (2013) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2013.09.050 · Cited by 309
Kenmotsu, H., Naito, T., Kimura, M., Ono, A., Shukuya, T., Nakamura, Y., Tsuya, A., Kaira, K., Murakami, H., Takahashi, T., et al. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318216ee6b · Cited by 214
Yamaguchi, T., Shimizu, J., Hasegawa, T., Horio, Y., Inaba, Y., Yatabe, Y., & Hida, T. (2018) · Lung Cancer · doi:10.1016/j.lungcan.2018.10.001 · Cited by 152
Minegishi, Y., Sudoh, J., Kuribayasi, H., Mizutani, H., Seike, M., Azuma, A., Yoshimura, A., Kudoh, S., & Gemma, A. (2010) · Lung Cancer · doi:10.1016/j.lungcan.2010.04.014 · Cited by 145
Self-citationComorbidities in the management of patients with lung cancer
Leduc, C., Antoni, D., Charloux, A., Falcoz, P., & Quoix, É. (2017) · European Respiratory Journal · doi:10.1183/13993003.01721-2016 · Cited by 158
Japanese guideline for the treatment of idiopathic pulmonary fibrosis
Homma, S. A., Bando, M., Azuma, A., Sakamoto, S., Sugino, K., Ishii, Y., Izumi, S., Inase, N., Inoue, Y., Ebina, M., et al. (2018) · Respiratory Investigation · doi:10.1016/j.resinv.2018.03.003 · Cited by 123
Self-citationSaito, Y., Kawai, Y., Takahashi, N., Ikeya, T., Murai, K., Kawabata, Y., & Hoshi, E. (2011) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2011.06.055 · Cited by 110
Satō, T., Kondo, H., Watanabe, A., Nakajima, J., Niwa, H., Horio, H., Okami, J., Okumura, N., Sugio, K., Teramukai, S., et al. (2014) · General Thoracic and Cardiovascular Surgery · doi:10.1007/s11748-014-0487-6 · Cited by 107
The Syndrome of Combined Pulmonary Fibrosis and Emphysema
Cottin, V., & Cordier, J.-F. (2009) · CHEST Journal · doi:10.1378/chest.09-0538 · Cited by 106
Treatment and outcome of lung cancer in idiopathic interstitial pneumonias.
Kreuter, M., Ehlers-Tenenbaum, S., Schaaf, M., Oltmanns, U., Palmowski, K., Hoffmann, H., Schnabel, P. A., Heußel, C. P., Puderbach, M., Herth, F. J. F., et al. (2015) · Sarcoidosis vasculitis and diffuse lung diseases · Cited by 92
Otsubo, K., Kishimoto, J., Ando, M., Kenmotsu, H., Minegishi, Y., Horinouchi, H., Kato, T., Ichihara, E., Kondo, M., Atagi, S., et al. (2022) · European Respiratory Journal · doi:10.1183/13993003.00380-2022 · Cited by 89
Self-citationMiura, Y., Saito, T., Tanaka, T., Takoi, H., Yatagai, Y., Inomata, M., Nei, T., Saito, Y., Gemma, A., & Azuma, A. (2017) · Respiratory Investigation · doi:10.1016/j.resinv.2017.09.007 · Cited by 80
Self-citationPulmonary Resection for Lung Cancer in Patients With Idiopathic Interstitial Pneumonia
Omori, T., Tajiri, M., Baba, T., Ogura, T., Iwasawa, T., Okudela, K., Takemura, T., Oba, M. S., Maehara, T., Nakayama, H., et al. (2015) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2015.03.094 · Cited by 80
Lung Cancer in Combined Pulmonary Fibrosis and Emphysema: A Series of 47 Western Patients
Girard, N., Marchand-Adam, S., Naccache, J., Borie, R., Urban, T., Jouneau, S., Marchand, É., Ravel, A.-C., Kiakouama, L., Mastroïanni, B., et al. (2014) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000209 · Cited by 76
Chronic obstructive pulmonary disease as a risk factor for lung cancer
Takiguchi, Y. (2014) · World Journal of Clinical Oncology · doi:10.5306/wjco.v5.i4.660 · Cited by 75
Kenmotsu, H., Yoh, K., Mori, K., Ono, A., Baba, T., Fujiwara, Y., Yamaguchi, O., Ko, R., Okamoto, H., Yamamoto, N., et al. (2019) · Cancer Science · doi:10.1111/cas.14217 · Cited by 73
Kenmotsu, H., Naito, T., Mori, K. P., Ko, R., Ono, A., Wakuda, K., Imai, H., Taira, T., Murakami, H., Endo, M., et al. (2015) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-014-2670-y · Cited by 68
Minegishi, Y., Kuribayashi, H., Kitamura, K., Mizutani, H., Kosaihira, S., Okano, T., Seike, M., Azuma, A., Yoshimura, A., Kudoh, S., et al. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3182103d3c · Cited by 69
Self-citationEfficacy of Chemotherapy for Advanced Non-Small Cell Lung Cancer with Idiopathic Pulmonary Fibrosis
Watanabe, N., Taniguchi, H., Kondoh, Y., Kimura, T., Kataoka, K., Nishiyama, O., Kondo, M., & Hasegawa, Y. (2012) · Respiration · doi:10.1159/000342046 · Cited by 66
Management of Lung Cancer in the Patient with Interstitial Lung Disease
Frank, A. J., Dagogo‐Jack, I., Dobre, I. A., Tait, S. D., Schumacher, L., Fintelmann, F. J., Fingerman, L. M., Keane, F. K., & Montesi, S. B. (2022) · The Oncologist · doi:10.1093/oncolo/oyac226 · Cited by 67
Shintani, Y., Ohta, M., Iwasaki, T., Ikeda, N., Tomita, E., Kawahara, K., & Ohno, Y. (2010) · General Thoracic and Cardiovascular Surgery · doi:10.1007/s11748-009-0569-z · Cited by 59
Sanuki, N., Ono, A., Komatsu, E., Kamei, N., Akamine, S., Yamazaki, T., Mizunoe, S., & Maeda, T. (2012) · Journal of Radiation Research · doi:10.1269/jrr.110142 · Cited by 57
Enomoto, Y., Inui, N., Kato, T., Baba, T., Karayama, M., Nakamura, Y., Ogura, T., & Suda, T. (2016) · Lung Cancer · doi:10.1016/j.lungcan.2016.03.017 · Cited by 55
Shimizu, R., Fujimoto, D., Kato, R., Otoshi, T., Kawamura, T., Tamai, K., Matsumoto, T., Nagata, K., Otsuka, K., Nakagawa, A., et al. (2014) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-014-2590-x · Cited by 54
Postoperative Acute Exacerbation of IPF after Lung Resection for Primary Lung Cancer
Watanabe, A., Kawaharada, N., & Higami, T. (2011) · Pulmonary Medicine · doi:10.1155/2011/960316 · Cited by 52
Ogura, T., Takigawa, N., Tomii, K., Kishi, K., Inoue, Y., Ichihara, E., Homma, S. A., Takahashi, K., Akamatsu, H., Ikeda, S., et al. (2019) · Respiratory Investigation · doi:10.1016/j.resinv.2019.06.001 · Cited by 52
Self-citationAcute exacerbation of idiopathic pulmonary fibrosis: a clinical review
Luppi, F., Cerri, S., Taddei, S., Ferrara, G., & Cottin, V. (2015) · Internal and Emergency Medicine · doi:10.1007/s11739-015-1204-x · Cited by 51
Surgical treatment for primary lung cancer combined with idiopathic pulmonary fibrosis
Watanabe, A., Miyajima, M., Mishina, T., Nakazawa, J., Harada, R., Kawaharada, N., & Higami, T. (2012) · General Thoracic and Cardiovascular Surgery · doi:10.1007/s11748-012-0180-6 · Cited by 50
Sakurada, T., Kakiuchi, S., Tajima, S., Horinouchi, Y., Okada, N., Nishisako, H., Nakamura, T., Teraoka, K., Kawazoe, K., Yanagawa, H., et al. (2015) · Annals of Pharmacotherapy · doi:10.1177/1060028014566446 · Cited by 48
Asahina, H., Oizumi, S., Takamura, K., Harada, T., Harada, M., Yokouchi, H., Kanazawa, K., Fujita, Y., Kojima, T., Sugaya, F., et al. (2019) · Lung Cancer · doi:10.1016/j.lungcan.2019.09.020 · Cited by 47
Otsubo, K., Kishimoto, J., Kenmotsu, H., Minegishi, Y., Ichihara, E., Shiraki, A., Kato, T., Atagi, S., Horinouchi, H., Ando, M., et al. (2017) · Clinical Lung Cancer · doi:10.1016/j.cllc.2017.06.003 · Cited by 46
Self-citationTogashi, Y., Masago, K., Handa, T., Tanizawa, K., Okuda, C., Sakamori, Y., Nagai, H., Kim, Y. H., & Mishima, M. (2011) · Clinical Lung Cancer · doi:10.1016/j.cllc.2011.11.001 · Cited by 44
Acute exacerbations in patients with idiopathic pulmonary fibrosis
Kim, D. W. (2013) · Respiratory Research · doi:10.1186/1465-9921-14-86 · Cited by 44
YAMAGUCHI, S., Ohguri, T., Matsuki, Y., Yahara, K., Oki, H., Imada, H., Narisada, H., & Korogi, Y. (2014) · International Journal of Clinical Oncology · doi:10.1007/s10147-014-0679-1 · Cited by 43
Watanabe, N., Niho, S., Kirita, K., Umemura, S., Matsumoto, S., Yoh, K., Ohmatsu, H., & Goto, K. (2015) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-015-2775-y · Cited by 42
Minegishi, Y., Kokuho, N., Miura, Y., Matsumoto, M., Miyanaga, A., Noro, R., Saito, Y., Seike, M., Kubota, K., Azuma, A., et al. (2014) · Lung Cancer · doi:10.1016/j.lungcan.2014.05.016 · Cited by 39
Self-citationAcute Exacerbation of Idiopathic Pulmonary Fibrosis
Kim, D. S. (2012) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2012.01.001 · Cited by 37
Perioperative pirfenidone treatment for lung cancer patients with idiopathic pulmonary fibrosis
Kanayama, M., Mori, M., Matsumiya, H., Taira, A., Shinohara, S., Kuwata, T., Imanishi, N., Yoneda, K., Kuroda, K., & Tanaka, F. (2019) · Surgery Today · doi:10.1007/s00595-019-01923-5 · Cited by 34
Okuda, K., Hirose, T., Oki, Y., Murata, Y., Kusumoto, S., Sugiyama, T., Ishida, H., Shirai, T., Nakashima, M., Yamaoka, T., et al. (2012) · PubMed · Cited by 33
Fukuizumi, A., Minegishi, Y., Omori, M., Atsumi, K., Takano, N., Hisakane, K., Takahashi, S., KOBAYASHI, K. P., Sugano, T., Takeuchi, S., et al. (2019) · International Journal of Clinical Oncology · doi:10.1007/s10147-019-01516-9 · Cited by 32
Self-citationMinegishi, Y., Gemma, A., Homma, S. A., Kishi, K., Azuma, A., Ogura, T., Hamada, N., Taniguchi, H., Hattori, N., Nishioka, Y., et al. (2020) · ERJ Open Research · doi:10.1183/23120541.00184-2019 · Cited by 31
Self-citationYoshida, T., Yoh, K., Goto, K., Niho, S., Umemura, S., Ohmatsu, H., & Ohe, Y. (2013) · PubMed · Cited by 31
Goto, T. (2018) · Cancers · doi:10.3390/cancers10070223 · Cited by 29
Chemoradiotherapy for locally advanced lung cancer patients with interstitial lung abnormalities
Higo, H., Kubo, T., Makimoto, S., Makimoto, G., Ihara, H., Masaoka, Y., Ninomiya, T., Ichihara, E., Ohashi, K., Satô, A., et al. (2019) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyz016 · Cited by 30
Yamaguchi, T., Shimizu, J., Hasegawa, T., Horio, Y., Inaba, Y., Hanai, N., Muro, K., & Hida, T. (2021) · BMC Cancer · doi:10.1186/s12885-021-08661-3 · Cited by 30
Yasuda, Y., Hattori, Y., Tohnai, R., Ito, S., Kawa, Y., Kono, Y., Urata, Y., Nogami, M., Takenaka, D., Negoro, S., et al. (2017) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyx142 · Cited by 28
Enomoto, Y., Inui, N., Imokawa, S., Karayama, M., Hasegawa, H., Ozawa, Y., Matsui, T., Yokomura, K., & Suda, T. (2015) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-015-2816-6 · Cited by 28
Hanibuchi, M., Kakiuchi, S., Atagi, S., Ogushi, F., Shimizu, E., Haku, T., Toyoda, Y., Azuma, M., Kondo, M., Kawano, H., et al. (2018) · Lung Cancer · doi:10.1016/j.lungcan.2018.09.007 · Cited by 28
Sekihara, K., Aokage, K., Oki, T., Omori, T., Katsumata, S., Ueda, T., Miyoshi, T., Goto, M., Nakasone, S., Ichikawa, T., et al. (2017) · Interactive Cardiovascular and Thoracic Surgery · doi:10.1093/icvts/ivx400 · Cited by 27
Kobayashi, H., Omori, S., Nakashima, K., Wakuda, K., Ono, A., Kenmotsu, H., Naito, T., Murakami, H., Endo, M., & Takahashi, T. (2017) · Respirology · doi:10.1111/resp.13075 · Cited by 27
Kimura, T., Nojiri, T., Hosoda, H., Shintani, Y., Inoue, M., Miyazato, M., Okumura, M., & Kangawa, K. (2015) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezv261 · Cited by 26
Kakiuchi, S., Hanibuchi, M., Tezuka, T., Saijo, A., Otsuka, K., Sakaguchi, S., Toyoda, Y., Goto, H., Kawano, H., Azuma, M., et al. (2016) · Respiratory Investigation · doi:10.1016/j.resinv.2016.10.008 · Cited by 25
Chen, Y. J., Chen, L. X., Han, M., Zhang, T. S., Zhou, Z. R., & Zhong, D. S. (2015) · Medicine · doi:10.1097/md.0000000000001451 · Cited by 25
Acute exacerbations of interstitial lung diseases
Papanikolaou, I. C., Drakopanagiotakis, F., & Polychronopoulos, V. (2010) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e32833ae49d · Cited by 25
Akaike, K., Saruwatari, K., Oda, S., Shiraishi, S., Takahashi, H., Hamada, S., Iyama, S., Horio, Y., Tomita, Y., Saeki, S., et al. (2020) · International Journal of Clinical Oncology · doi:10.1007/s10147-019-01584-x · Cited by 23
Managing Lung Cancer with Comorbid Interstitial Pneumonia
Ichihara, E., Miyahara, N., Maeda, Y., & Kiura, K. (2019) · Internal Medicine · doi:10.2169/internalmedicine.3481-19 · Cited by 22
Current Treatment Strategies for Non-Small-Cell Lung Cancer with Comorbid Interstitial Pneumonia
Ikeda, S., Kato, T., Kenmotsu, H., Sekine, A., Baba, T., & Ogura, T. (2021) · Cancers · doi:10.3390/cancers13163979 · Cited by 23
Niwa, H., Nakahara, Y., Yokoba, M., Mitsufuji, H., Sasaki, J., & Masuda, N. (2017) · Molecular and Clinical Oncology · doi:10.3892/mco.2017.1359 · Cited by 20
Kikuchi, R., Takoi, H., Tsuji, T., Nagatomo, Y., Tanaka, A., Kinoshita, H., Ono, M., Ishiwari, M., Toriyama, K., Kono, Y., et al. (2021) · Thoracic Cancer · doi:10.1111/1759-7714.13900 · Cited by 19
Self-citationOkano, N., Suefuji, H., Nakajima, M., Tokumaru, S., Kubo, N., Yoshida, D., Suzuki, O., Ishikawa, H., Satouchi, M., Nakayama, H., et al. (2023) · Journal of Radiation Research · doi:10.1093/jrr/rrad008 · Cited by 20
Okano, N., Kubo, N., Yamaguchi, K., Kouno, S., Miyasaka, Y., Mizukami, T., Shirai, K., Saitoh, J., Ebara, T., Kawamura, H., et al. (2021) · Cancers · doi:10.3390/cancers13164204 · Cited by 19
Asai, N., Katsuda, E., Hamanaka, R., Kosaka, K., Matsubara, A., Nishimura, M., Tanaka, H., Yokoe, N., Takahashi, A., Yamaguchi, E., et al. (2016) · Tumori Journal · doi:10.5301/tj.5000574 · Cited by 19
Kobayashi, H., Naito, T., Omae, K., Omori, S., Nakashima, K., Wakuda, K., Ono, A., Kenmotsu, H., Murakami, H., Endo, M., et al. (2018) · Lung Cancer · doi:10.1016/j.lungcan.2018.04.023 · Cited by 19
Taya, T., Chiba, H., Yamada, G., Takahashi, M., Ikeda, K., Mori, Y., Otsuka, M., & Takahashi, H. (2019) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyz115 · Cited by 18
Nakao, S., Yamaguchi, K., Sakamoto, S., Horimasu, Y., Masuda, T., Miyamoto, S., Nakashima, T., Iwamoto, H., Fujitaka, K., Hamada, H., et al. (2019) · Anticancer Research · doi:10.21873/anticanres.13773 · Cited by 17
Wang, Y., Miao, L., Hu, Y., & Zhou, Y. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01636 · Cited by 17
Nagano, T., Kotani, Y., Fujii, O., Demizu, Y., Niwa, Y., Ohno, Y., Nishio, W., Itoh, T., Murakami, M., & Nishimura, Y. (2012) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hys115 · Cited by 16
Kikuchi, R., Takoi, H., Tsuji, T., Nagatomo, Y., Tanaka, A., Kinoshita, H., Ono, M., Ishiwari, M., Toriyama, K., Kono, Y., et al. (2021) · Thoracic Cancer · doi:10.1111/1759-7714.13792 · Cited by 15
Self-citationMasuda, T., Hirano, C., Horimasu, Y., Nakashima, T., Miyamoto, S., Iwamoto, H., Ohshimo, S., Fujitaka, K., Hamada, H., & Hattori, N. (2017) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-017-3476-5 · Cited by 15
Doi, H., Nakamatsu, K., & Nishimura, Y. (2019) · International Journal of Clinical Oncology · doi:10.1007/s10147-019-01432-y · Cited by 15
Miyamura, T., Sakamoto, N., Kakugawa, T., Okuno, D., Yura, H., Nakashima, S., Ishimoto, H., Kido, T., Taniguchi, D., Miyazaki, T., et al. (2019) · Respiratory Research · doi:10.1186/s12931-019-1128-5 · Cited by 14
An analysis of the clinical features of lung cancer in patients with connective tissue diseases
Saijo, A., Hanibuchi, M., Goto, H., Toyoda, Y., Tezuka, T., & Nishioka, Y. (2017) · Respiratory Investigation · doi:10.1016/j.resinv.2016.11.003 · Cited by 14
Taniguchi, D., Yamasaki, N., Miyazaki, T., Tsuchiya, T., Matsumoto, K., Hatachi, G., Kakugawa, T., Sakamoto, N., Mukae, H., & Nagayasu, T. (2017) · Surgery Today · doi:10.1007/s00595-017-1551-5 · Cited by 14
Nakao, S., Yamaguchi, K., Iwamoto, H., Sakamoto, S., Horimasu, Y., Masuda, T., Miyamoto, S., Nakashima, T., Ohshimo, S., Fujitaka, K., et al. (2020) · Respiratory Medicine · doi:10.1016/j.rmed.2020.106131 · Cited by 14
Kanaji, N., Shimizu, J., Sakai, K., Ueda, Y., Miyawaki, H., Watanabe, N., Uemura, T., Hida, T., Inoue, T., Watanabe, N., et al. (2020) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753466620963866 · Cited by 13
Medical anticancer treatment of lung cancer associated with comorbidities: A review
Sculier, J., Botta, I., Bucalau, A., Compagnie, M. J., Eskenazi, A., Fischler, R., Gorham, J., Mans, L., Rozen, L., Speybrouck, S., et al. (2015) · Lung Cancer · doi:10.1016/j.lungcan.2015.01.007 · Cited by 13
Yasuda, Y., Nomizo, T., Ozasa, H., Funazo, T. Y., Tsuji, T., Yoshida, H., Sakamori, Y., Nagai, H., Handa, T., Kubo, T., et al. (2017) · Molecular and Clinical Oncology · doi:10.3892/mco.2017.1373 · Cited by 12
18F-FDG PET/CT predicts acute exacerbation in idiopathic pulmonary fibrosis after thoracic surgery
Yoon, H., Lee, S. H., Ha, S., Ryu, J., & Song, J. W. (2021) · BMC Pulmonary Medicine · doi:10.1186/s12890-021-01659-4 · Cited by 13
Miyajima, M., Watanabe, A., Satō, T., Teramukai, S., Ebina, M., Kishi, K., Sugiyama, Y., Kondo, H., Kobayashi, S., Takahashi, Y., et al. (2017) · Surgery Today · doi:10.1007/s00595-017-1605-8 · Cited by 12
Igawa, S., Nishinarita, N., Takakura, A., Ozawa, T., Harada, S., Kusuhara, S., Niwa, H., Hosotani, S., Sone, H., Nakahara, Y., et al. (2018) · Cancer Management and Research · doi:10.2147/cmar.s189556 · Cited by 12
Ito, K., Hashimoto, K., Kaira, K., Yamaguchi, O., Mouri, A., Shiono, A., Miura, Y., Kobayashi, K., Imai, H., Kuji, I., et al. (2024) · Oncology Letters · doi:10.3892/ol.2024.14243 · Cited by 11
Xiaohong, X., Liqiang, W., Na, L., Xinqing, L., Yin-yin, Q., Ming, L., Ming, O., Qian, H., Qun, L., Li, S., et al. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.660800 · Cited by 10
Second-line Chemotherapy for Patients with Small Cell Lung Cancer and Interstitial Lung Disease.
Fujimoto, D., Shimizu, R., Kato, R., Sato, Y., Kogo, M., Ito, J., Teraoka, S., Otoshi, T., Nagata, K., Nakagawa, A., et al. (2015) · PubMed · Cited by 11
Radiotherapy of Lung Tumours in Idiopathic Pulmonary Fibrosis
Kolek, V., Vašáková, M., Šterclová, M., Cwiertka, K., Vrána, D., Kudláček, A., Skřičková, J., Pešek, M., & Petera, J. (2017) · Klinicka onkologie · doi:10.14735/amko2017303 · Cited by 11
Miyamoto, H., Takemura, S., Minamiyama, Y., Tsukioka, T., Toda, M., Nishiyama, N., & Shibata, T. (2021) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.21-7 · Cited by 9
Isobe, K., Kaburaki, K., Kobayashi, H., Sano, G., Sakamoto, S., Takai, Y., Makino, T., Tochigi, N., Iyoda, A., & Homma, S. A. (2018) · Lung Cancer · doi:10.1016/j.lungcan.2018.10.008 · Cited by 9
Omori, M., Minegishi, Y., Uruga, H., Fukuizumi, A., Isobe, K., Izumi, S., Koyama, R., Bando, M., Sugiyama, H., Takahashi, K., et al. (2023) · Respiratory Investigation · doi:10.1016/j.resinv.2023.06.002 · Cited by 9
Self-citationOgawa, K., Uruga, H., Fujii, T., Fujimori, S., Kohno, T., Kurosaki, A., Kishi, K., & Abe, S. (2020) · BMC Pulmonary Medicine · doi:10.1186/s12890-020-01347-9 · Cited by 8
Acute Exacerbation of Idiopathic Pulmonary Fibrosis
Kim, D. S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11454-0 · Cited by 8
Miyamoto, A., Michimae, H., Nakahara, Y., Akagawa, S., Nakagawa, K., Minegishi, Y., Ogura, T., Hontsu, S., Date, H., Takahashi, K., et al. (2022) · Respiratory Investigation · doi:10.1016/j.resinv.2022.10.009 · Cited by 7
Self-citationInvasive Diagnostic Strategies in Immunosuppressed Patients with Acute Respiratory Distress Syndrome
Sanchez, J. F., Ghamande, S. A., Midturi, J. K., & Arroliga, A. C. (2014) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2014.08.008 · Cited by 7
Shirasawa, M., Fukui, T., Kusuhara, S., Hiyoshi, Y., Nakahara, Y., Nishinarita, N., Igawa, S., & Naoki, K. (2019) · BMC Cancer · doi:10.1186/s12885-019-5367-0 · Cited by 7
Koda, K., Enomoto, Y., Aoshima, Y., Amano, Y., Kato, S., Hasegawa, H., Matsui, T., Yokomura, K., Mochizuki, E., Matsuura, S., et al. (2022) · Therapeutic Advances in Chronic Disease · doi:10.1177/20406223221108395 · Cited by 8
Castelli, G., Cocconcelli, E., Grimaudo, G., Leo, I. D., Bellani, S., Fiorentù, G., Giulianelli, G., Bernardinello, N., Balestro, E., & Spagnolo, P. (2025) · Journal of Personalized Medicine · doi:10.3390/jpm15050213 · Cited by 7
Sekine, A., Matama, G., Hagiwara, E., Tabata, E., Ikeda, S., Oda, T., Okuda, R., Kitamura, H., Baba, T., Satoh, H., et al. (2022) · Thoracic Cancer · doi:10.1111/1759-7714.14566 · Cited by 6
The Syndrome of Combined Pulmonary Fibrosis and Emphysema
Cottin, V. (2023) · Springer eBooks · doi:10.1007/978-3-031-12950-6_33 · Cited by 6
Modified risk scoring system for acute exacerbation of interstitial lung disease
Kanayama, M., Osaki, T., Nishizawa, N., Nakagawa, M., So, T., & Kodate, M. (2018) · Asian Cardiovascular and Thoracic Annals · doi:10.1177/0218492318816229 · Cited by 4
Ito, N., Masuda, T., Nakashima, T., Nakao, S., Yamaguchi, K., Sakamoto, S., Horimasu, Y., Miyamoto, S., Iwamoto, H., Fujitaka, K., et al. (2021) · Anticancer Research · doi:10.21873/anticanres.14908 · Cited by 4
Otani, T., Yamaguchi, K., Nakao, S., Sakamoto, S., Horimasu, Y., Masuda, T., Miyamoto, S., Nakashima, T., Iwamoto, H., Fujitaka, K., et al. (2021) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-021-04341-y · Cited by 4
Hanibuchi, M., Ogino, H., Sato, S., & Nishioka, Y. (2024) · The Journal of Medical Investigation · doi:10.2152/jmi.71.9 · Cited by 3
Metadata
- Authors
- Minegishi, Y., Takenaka, K., Mizutani, H., Sudoh, J., Noro, R., Okano, T., Azuma, A., Yoshimura, A., Ando, M., Tsuboi, E., Kudoh, S., & Gemma, A.
- Affiliations
- Nippon Medical School (JP)
- Division of Internal Medicine, Tsuboi Cancer Center Hospital
- Venue
- Internal Medicine
- Published
- 2009
- Volume
- 48
- Issue
- 9
- Pages
- 665-672
- ISSN
- 0918-2918 (ISSN-L)
- 1349-7235
- OpenAlex
- W2094116236
- Cited by
- 128
- References
- 34
- Citations by year
- 2025: 3 · 2024: 4 · 2023: 4 · 2022: 6 · 2021: 13 · 2020: 7 · 2019: 15 · 2018: 10 · 2017: 17 · 2016: 4 · 2015: 16 · 2014: 9 · 2013: 3 · 2012: 6
- FWCI
- 4.75
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Japan Society for the Promotion of Science (21591006)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Diagnosis and Treatment
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
- Keywords
- idiopathic interstitial pneumonia, lung cancer, acute exacerbation, chemotherapy-induced lung injury, carboplatin, paclitaxel, etoposide, platinum agents, C-reactive protein, best supportive care, treatment selection
- MeSH terms
- Aged, Aged, 80 and over, Antineoplastic Agents, Female, Humans, Lung Neoplasms, Male, Middle Aged, Retrospective Studies, Survival Rate, Idiopathic Interstitial Pneumonias
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
